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Solid-phase syntheses of novel receptors featuring a 2,6-di-
amidopyridine ‘‘head’’ group and bearing sulfonamidopep-
tide sidearms are described. NMR conformational studies
show that the ‘‘two-armed’’ receptors collapse into an intram-
olecularly folded structure through formation of a hydrogen-
bonding network. In order to accommodate the guests, re-
Introduction
Noncovalent interactions play an important role in sta-
bilising the secondary structures of natural biopolymers
(peptides, polysaccharides and oligonucleotides) and pro-
moting the binding of natural or synthetic receptors to their
targets. Synthetic receptors for biologically relevant sub-
strates such as amino acids and peptides are of increasing
importance for possible applications in molecular recogni-
tion (enantioselective binding, separation of racemates) and
as potential biosensors, therapeutics and catalysts.
In the field of synthetic receptors, several macrocyclic
hosts have been prepared and have been shown to bind am-
ino acids or peptide fragments with excellent selectivity.[123]
During the last decade, a few studies focused on a different
class of receptors for peptides; these were called ‘‘tweezer
receptors’’ or ‘‘two-armed’’ receptors.[4] In the structure of
tweezer receptors, the ‘‘linker’’ (or ‘‘head group’’ or
‘‘hinge’’) is typically a conformationally restricted moiety
such as a 1,2-diamine,[5] a steroidal core,[6] a guanidini-
um,[7a] a thiourea,[7b] or a dibenzofuran.[8] The ‘‘linker’’ co-
valently binds and directs two functionalised substrate-
binding arms. The two sidearms may be macrocyclic oligo-
mers[5] or simple peptides.[628] Whereas in many tweezer
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ceptors have to unfold, breaking the intramolecular hydro-
gen bonds. The absolute binding constants of receptors with
N-protected amino acids and dipeptides are therefore rela-
tively weak. However, one receptor shows a high selectivity
for N-Cbz-D-Ala-D-AlaOH over its enantiomer N-Cbz-L-Ala-
L-AlaOH.
receptor systems the head group plays only a limited role
in the binding of the guest, the group in Southampton has
recently developed tweezer receptors that make use of a di-
amidopyridine moiety as the head group. This can specific-
ally bind to carboxylic acid functionalities, and such
tweezers, with peptidic arms, have proved to be selective
receptors for peptides with a carboxylic acid terminus.[9]
The diamidopyridine moiety also proved to be a highly effi-
cient carboxylic acid binding site (CBS) when incorporated
into macrocyclic receptors.[1b,10]
Recently, an interest in synthetic receptors based on pep-
tidosulfonamide sidearms has also emerged.[3,11213] Over
the past five years, the group in Milano has been studying
the conformational preferences of unnatural biopolymer
scaffolds containing â-sulfonamidopeptides[14] and vinylog-
ous sulfonamidopeptides.[15] Sulfonamidopeptides display
an aspect of the covalent framework that is essential for the
formation of folded structures by intramolecular hydrogen
bonding: The repeating backbone structure contains both
hydrogen-bond donors (strong: CONH; very strong:
SO2NH) and hydrogen-bond acceptors (strong: C5O;
weak: SO2N).[14,15] In this paper we report the synthesis and
conformational and binding studies of a novel class of
‘‘two-armed’’ synthetic receptors for N-protected amino ac-
ids and dipeptides, each containing a 2,6-diamidopyridine
binding unit bearing pendant pseudo-peptide legs con-
sisting of an amino acid (-Phe) and chiral â-aminosulfon-
amides.[16] One of these receptors in particular (5, Figure 1)
displays a high binding selectivity for the dipeptide N-Cbz-
-Ala--AlaOH (Cbz 5 benzyloxycarbonyl) over its enan-
tiomer N-Cbz--Ala--AlaOH.[16]
Results and Discussion
The synthesis of compounds 123 was accomplished on
solid phase, starting from N-Fmoc-Gly Wang resin 6 (load-
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Figure 1. Labelling of hydrogen atoms in receptor 5
ing 0.88 mmol/g) (Scheme 1) [Fmoc 5 N-(9-fluorenylme-
thoxycarbonyl)]. After deprotection of the Fmoc-Gly Wang
resin, ‘‘hinge’’ 7[9] was coupled using a 20% excess of resin
to give 9. The unchanged amino groups on the resin were
capped with acetylimidazole (AcIm). Deprotection of the
Fmoc groups and treatment with the -valine-derived â-N-
Fmoc-aminosulfonyl chloride 8, with DMAP as catalyst
and methyl trimethylsilyl dimethylketene acetal (MTDA) as
HCl scavenger,[14,17] gave the bis(sulfonamide) 10. Two
cycles were required to ensure completion of the coupling,
until no free amino groups could be detected by two differ-
ent colour tests.[18] Cleavage of the Fmoc protecting groups,
followed by acetylation or mesylation, gave bis(sulfonam-
ide) derivatives with two different terminal groups. Release
of the resin-bound products was accomplished either by a
direct basic methanolysis to provide the methyl ester deriv-
atives 1 and 2, or alternatively by acidic TFA/H2O cleavage
followed by esterification (two steps, but easier to purify).
Compound 3 was synthesized starting from compound 9 by
Fmoc deprotection followed by acetylation and cleavage
from the resin (basic methanolysis).
The conformations of compounds 123 in solution were
studied by NMR spectroscopy. In the 1H NMR spectrum
of 1 in CDCl3, the peaks were rather broad, indicating a
slow conformational equilibrium at room temperature (on
the NMR timescale). Assignment of all the proton signals
of receptor 1 could, however, be made unambiguously by
means of COSY and TOCSY experiments (Figure 2). In
CD3COCD3 or CD3SOCD3, in contrast, the spectra were
well resolved, showing single sets of resonances and proving
the absence of diastereomeric mixtures (also proved by the
13C NMR spectrum). The N2H protons, H1 to H3, dis-
played a fairly small concentration dependence in CDCl3
(or in CD2Cl2), which suggests that compound 1 essentially
does not aggregate in the concentration range under consid-
eration (1.25220 m, see associated electronic Supporting
Information).[19] At a concentration of 8.5 m in CDCl3,
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Scheme 1. Reagents and conditions: (i) piperidine [20% in N,N-
dimethylformamide (DMF)]; (ii) 7, 1,3-diisopropylcarbodiimide
(DIC), 1-hydroxybenzotriazole hydrate (HOBT), 4-(dimethyl-
amino)pyridine (DMAP), dichloromethane (DCM); (iii) acetylim-
idazole (Aclm), DCM; (iv) 8, DMAP, methyl trimethylsilyl di-
methylketene acetal (MTDA), DCM, two cycles; (v) Et3N, MeOH,
DMF; (vi) trifluoroacetic acid (TFA), H2O; (vii) 1-(3-dimethylami-
nopropyl)-3-ethylcarbodiimide hydrochloride (EDC), DMAP,
MeOH, THF; (viii) methanesulfonyl chloride (MsCl), Et3N, DCM
the signal of the amidopyridine NH1 protons appeared at
unexpectedly low field (ä 5 9.41, see Table 1, standard
values ä 5 8.0028.50[1b][10a]), whilst the sulfonamide pro-
tons NH2 were also strongly deshielded (ä 5 6.32 compared
to their standard values ä 5 4.5024.74).[14] The acetamide
NH3 proton signals were located closer to their traditional
chemical shifts (ä 5 6.22 compared to 6.0026.20).
The temperature dependence of protons H1 to H3 was
studied between 298 and 313 K, at a concentration of
1.5 m in CDCl3. Unfortunately, the dependence at low
temperatures could not be studied because of the limited
solubility of compound 1 in CDCl3 and in CD2Cl2. Calcu-
lated values of ˜ä/˜T for H1, H2, H3 are 29.8, 23.8, and
25.8 ppb/K, respectively, over the range of temperatures
studied (see associated electronic Supporting Informa-
tion).[19] These temperature coefficients indicate various de-
grees of intramolecular hydrogen bonding and equilibria
with non-hydrogen-bonded states.[14,15,20]
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Figure 2. Labelling of hydrogen atoms in receptors 1 and 2
Table 1. Chemical shifts of NH protons H1 to H3 for compounds
125 (8.5 m in CDCl3)
1 2 3 4 5Proton
N2H1 9.41[a] 9.07[a] 8.83[a] 8.87/8.75[a] 9.32[a]
N2H2 6.32[b] 5.13 (6.34)[b] [c] 6.56[d] 5.98[b] 5.78[b]
N2H3 6.22[d] 6.34 (5.13)[b] [c] 5.81[d] 6.38[b]
N2H4 6.22[d]
[a] Reference value for the amidopyridine protons: ä 5 8.0028.50,
see refs.[1b,10a] 2 [b] Reference value for the sulfonamide protons:
ä 5 4.5024.74, see ref.[14] 2 [c] N2H2 and N2H3 could not be
unequivocally attributed. 2 [d] Reference value for the carboxyam-
ide protons: ä 5 6.0026.20.
NOESY and ROESY experiments were performed for
compound 1 at two different concentrations (5 and 10 m
in CDCl3) and showed the same contact pattern. The CH3
acetyl hydrogen atoms (H9) gave cross-peaks with the pro-
ton of the valine stereogenic centre (H8) and with the NH
of the terminal acetamide (H3). While the cross-peak be-
tween H9 and H3 is typical of a trans-amide rotamer, the
cross-peak between H9 and H8 is indicative of the presence
of a cis-amide rotamer,[21,22] which is usually present as a
small percentage in secondary amides (ca. 3% for N-methyl-
acetamide in CHCl3).[23] The acetyl CH3 hydrogen atoms
(H9) also gave cross-peaks with the aromatic protons of the
phenylalanine ring and with the benzylic protons (H6).
Other interesting contacts are: The isopropyl CH3 protons
(H10) gave cross-peaks with the aromatic protons of the
phenylalanine ring; the proton at the phenylalanine ste-
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reogenic centre (H5) gave cross-peaks with protons CH2SO2
(H7), and with the isopropyl protons CH3 (H10) and the
isopropyl proton CH (H11). From the NOE data, and the
relatively downfield position of the NH signals in the 1H
NMR, we can conclude that ‘‘two-armed’’ receptor 1 col-
lapses into an intramolecularly folded structure through
formation of a hydrogen-bonding network involving the
amidopyridine moiety, the sulfonamide NH and the ter-
minal acetamide.
Analogous studies were conducted on the ‘‘two-armed’’
receptor 2 and gave similar results. In summary: (a) the
peaks were rather broad in the 1H NMR spectrum of 2 in
CDCl3, indicating a slow conformational equilibrium at
room temperature (on the NMR timescale); (b) protons H1,
H2 and H3 displayed a fairly small concentration depend-
ence in CDCl3, which suggests that compound 2 essentially
does not aggregate in the concentration range considered
(1.0222.5 m, see associated electronic Supporting In-
formation);[19] (c) the signal of the amidopyridine NH1 pro-
tons appeared at low field (ä 5 9.07; see Table 1), whilst the
sulfonamide NH2 and NH3 proton signals appeared at ä 5
6.34 and 5.13, indicating hydrogen bonding; (d) ROESY
experiments in CDCl3 (concentration: 5 m) showed the
presence of several cross-peaks indicative of an intramolec-
ularly collapsed structure similar to 1. In particular, the
cross-peaks between mesyl CH3 (H9) and isopropyl CH3
(H10), mesyl CH3 (H9) and CH of the valine stereocentre
(H8) were indicative of a cisoid conformation of the ter-
minal mesyl group. It was therefore concluded that an intra-
molecularly folded structure was also highly populated in
CDCl3 in this case, and that the presence of a poor hydro-
gen-bond acceptor such as the methanesulfonamide
group[14,15] in the terminal position was compensated for
by the very strong hydrogen-bond-donating ability of the
methanesulfonamide NH group.[14,15]
In comparison, the spectrum of the control compound 3
(Scheme 1) in CDCl3 was perfectly resolved, and the amido-
pyridine NH1 signal was found at ä 5 8.83 (for a concentra-
tion of 8.5 m, see Table 1), whereas the acetamide N2H
proton was found at ä 5 6.56. Protons H1 and H2 displayed
a fairly small concentration dependence in CDCl3, sug-
gesting that compound 3 essentially does not aggregate in
the concentration range under consideration (see associated
electronic Supporting Information).[19] ROESY experi-
ments in CDCl3 (concentration: 10 m) showed cross-peaks
consistent with the presence of trans-amide rotamers (a mi-
nor contact between CH3 of the terminal acetamide and
CH of the phenylalanine stereocentre was also detected, in-
dicating the presence of a small percentage of cis-amide rot-
amer).[22,23]
In order to obtain a simplified view of the system, and
to study the behaviour of the single legs of receptor 1, we
decided to prepare the differently substituted scaffold 4,
starting from the unsymmetrically protected ‘‘hinge’’ 11
(Scheme 2). As shown in Scheme 2, 11 was deprotected
(25% TFA in DCM), and treated with the -valine-derived
â-N-Boc-aminosulfonyl chloride 12, with DMAP as cata-
lyst and methyl trimethylsilyl dimethylketene acetal
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(MTDA) as HCl scavenger,[14,17] to give the monosulfonam-
ide 13. Removal of the Boc group (25% TFA in DCM) and
acetylation with acetylimidazole yielded receptor 4. 1H
NMR studies on receptor 4 (8.5 m in CDCl3) showed a
single set of well-resolved signals (see Table 1): The amidop-
yridine N2H proton signals (two different signals at ä 5
8.75 and 8.87) were shifted substantially upfield compared
to that of H1 of receptor 1 (ä 5 9.41), and the same effect
could be seen for the sulfonamide N2H proton (ä 5 5.98
vs. 6.32 for 1) and the acetamide N2H proton (ä 5 5.81
vs. 6.22 for 1). From these data we concluded that the hy-
drogen-bonding network in 1 and 2 was strengthened by
the cooperative effect of both legs. In the ROESY spectrum
(8.3 m in CDCl3) the acetamide methyl group gave cross-
peaks with the isopropyl CH3, the CH of the valine ste-
reocentre, and the acetamide NH. These contacts are typ-
ical of the presence both of a trans-amide rotamer and of a
cis-amide rotamer,[22,23] usually present in small percentages
in secondary amides (see the above discussion for 1).
Binding studies with receptor 1 in CDCl3 were carried
out with a series of substrates, by a standard titration ex-
periment, by monitoring the shift of the NH and CH sig-
nals on addition of successive aliquots of guest and analys-
ing the resulting binding curves by nonlinear regression
analysis.[24] In agreement with the above results, and as a
further proof of strong intramolecular self-association,
compound 1 proved to be a rather poor receptor for N-
protected (N-Boc and N-Cbz) amino acids and dipeptides
(see Table 2), even in a noncompetitive solvent such as chlo-
roform. A slightly higher affinity for N-Cbz-Ala-OH (either
 or ) in preference to N-Boc--Ala-OH was observed,
with binding constants of 207 (N-Cbz--Ala-OH), 270 (N-
Cbz--Ala-OH) and 119 (N-Boc--Ala-OH), but little en-
antioselective binding was observed with the N-Cbz-amino
acids. Binding of all three amino acid substrates gave rise
to significant downfield shifts in the amidopyridine NH1
signal ($ 0.5 ppm), but whereas binding of the  enanti-
omers produced a small upfield shift in the acetamide NH3
signal (ca. 0.1) and little change to the sulfonamide NH2
signal, the binding of N-Cbz--AlaOH produced a down-
field shift of the sulfonamide NH2 signal (ca. 0.4) and little
Table 2. Binding constants Kass (21) for the 1:1 complexes formed between receptors 1 and 5 and various amino acids and dipeptides
derivatives, calculated from the chemical shifts of various proton signals of 1 and 5, in CDCl3 at 25 °C
Guest Host 1 (Data[a]) Host 5 (Data[a])
Kass [21] Kass [21]
N-Boc--Ala-OH 119 (NH1, NH3) 2[b]
N-Cbz--Ala-OH 207 (NH1, NH3, CH72SO2) 32 (NH1)
N-Cbz--Ala-OH 270 (NH1, CH6H69Ph, CH6H69Ph) 2[b]
N-Boc--Ala--Ala-OH 361 (NH1, NH2) 2[b]
N-Cbz--Ala--Ala-OH 245 (NH1, NH2) 107 (NH1, CH2)
N-Cbz--Ala--Ala-OH 242 (NH2, NH3) 2404[c] (NH1, NH3, CH7H79Ph, CH7H79Ph, CH6,14)
N-Boc--Ala--Phe-OH 297 (NH1, NH2) 109 (NH1)
N-Cbz--Ala--Phe-OH 292 (NH1, NH2, NH3, CH6H69Ph) 2[b]
N-Boc--Ala--Trp-OH 377 (NH1, NH2) ND[d]
[a] Data from signals used in the binding calculation. 2 [b] Experiment not performed. 2 [c] Error was estimated as , 5%, with data from
five different proton signals. 2 [d] Changes in the spectrum were too small to allow reliable estimation of the binding constant.
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Scheme 2. Reagents and conditions: (i) TFA (25% in DCM); (ii)
K2CO3 (10% in H2O); (iii) 12, DMAP, MTDA, DCM; (iv) Aclm,
DCM
change to the acetamide NH3 signal. Saturation was re-
ached upon addition of an excess of N-protected amino
acid as guest (20230 equiv.). In more polar solvents such as
[D6]acetone, CD3CN or [D6]DMSO, the spectra were well
resolved, but the chemical shifts of the host signals did not
change upon addition of an excess of N-protected amino
acid.
Binding of dipeptide guests gave only slightly higher
binding constants, and titration of 1 with, for example, N-
Cbz--Ala--Ala-OH gave a binding constant of 245 21
and resulted in downfield shifts both of the amidopyridine
and of the sulfonamide NH signals (NH1: ˜ä 5 0.25; NH2:
˜ä 5 0.30) and an upfield shift of acetamide NH3 (˜ä 5
0.12). A change in the N-protecting group from Cbz to Boc
had only a small effect on the binding (or on the shifts of
the NH signals), while a change in the C-terminal amino
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acid from alanine to phenylalanine or tryptophan similarly
had only a limited effect. Titration with N-Cbz--Ala--
Ala-OH resulted in little change to the amidopyridine NH1
signal (˜ä # 0.03), but analysis of the downfield shift of
the sulfonamide NH2 signal (˜ä 5 0.28) and of the upfield
shift of the acetamide NH3 signal (˜ä 5 0.19) gave a bind-
ing constant of 242 21, indicating that 1 also shows little
enantioselectivity for dipeptides [Ka(N-Cbz--Ala--
AlaOH) 5 245 21; Table 2]. Binding of amino acids and
dipeptides was also accompanied by a small shift of several
CH signals in host 1 (# 0.12). The 1:1 stoichiometry of the
complexes between host 1 and the amino acidic and pep-
tidic guests was established by Scatchard plots,[25] and by
the good fit of the experimental data to the 1:1 model.[26]
In the binding experiments with host 1, we also mon-
itored the chemical shifts of the N-protected amino acid
and dipeptide guests. The carbamate NHa signals were
shifted downfield on binding of both amino acids (˜ä 5
0.0820.14) and dipeptides (˜ä 5 0.1020.35).[27] The amide
NHb signals on binding the dipeptides were also shifted
downfield with a ˜ä value similar to that of the NHa signals
(˜ä 5 0.1020.35).[27]
Thus, receptor 1 does appear to bind dipeptides and
simple amino acid derivatives, but the absolute binding con-
stants are rather low in comparison to those observed in
other diamidopyridine-based receptors, and the shifts of the
various NH signals on binding are also rather small in com-
parison to those seen in other related receptor systems.[1b,10]
In order to study the influence of the length of the legs
and possibly to increase the affinity of our ‘‘two-armed’’
receptors for N-protected amino acids and dipeptides, we
decided to test the new receptor 5, with longer pseudo-pep-
tide legs (Scheme 3). Compound 5 was synthesized from the
bis(sulfonamide) 10 (Scheme 1) by removal of the Fmoc
groups, treatment with the -valine-derived â-N-Fmoc-ami-
nosulfonyl chloride 8, and subsequent deprotection,
acetylation and cleavage (Scheme 3).
In the 1H NMR spectrum of 5 in CDCl3, the peaks were
rather broad, indicating a slow conformational equilibrium
at room temperature, as in the case of compound 1. Assign-
ment of all the proton signals of receptor 5 could, however,
be accomplished by means of COSY and TOCSY experi-
ments (Figure 1). The 1H NMR spectra at 320 K in CDCl3
and at 300 K in CD3COCD3 and in CD3CN were well re-
solved and showed single sets of resonances, proving the
absence of diastereomeric mixtures (also proved by the 13C
NMR spectra). The signals of N2H protons H1, H2, H3
and H4 displayed a fairly small concentration dependence
in CDCl3 (slightly higher for H3 compared to H1, H2 and
H4), suggesting that compound 5 essentially does not ag-
gregate in the concentration range under consideration
(0.47220 m, see associated electronic Supporting In-
formation).[19] At a concentration of 8.5 m in CDCl3, the
signal of the amidopyridine NH1 protons appeared at low
field (ä 5 9.32 compared to ä 5 8.0028.50 for reference
values,[1b][10a] see Table 1). The signals of the sulfonamide
protons NH2 and NH3 appeared at low field as well (ä 5
5.78 and 6.38 compared to ä 5 4.5024.74 for reference
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Scheme 3. Reagents and conditions: (i) piperidine (20% in DMF);
(ii) 8, DMAP, MTDA, DCM, two cycles; (iii) Aclm, DCM; (iv)
TFA, H2O; (v) EDC, DMAP, MeOH, THF
values[14]), suggesting intramolecular hydrogen bonding. In
contrast, the signal of the acetamide protons NH4 was
closer to the conventional value (ä 5 6.22 compared to ä 5
6.0026.20 for reference values).
The temperature dependence of protons H1 to H4 was
studied between 300 and 320 K, at a concentration of 1 m
in CDCl3. Calculated values of ˜ä/˜T for H1, H2, H3, H4
are 2 2.5, 2 4.8, 2 4.5, and 2 4.5 ppb/K, respectively, over
the range of temperatures studied (see associated electronic
Supporting Information).[19] These temperature coefficients
revealed a small temperature dependence in protons H1 to
H4, indicating various degrees of intramolecular hydrogen
bonding.
NOESY experiments were performed at a concentration
of 12 m in CDCl3, and showed some interesting contacts.
The CH3 acetyl hydrogen atoms (H15) gave a cross-peak
with the NH of the acetyl group (H4), which is typical of a
trans-amide rotamer [a minor contact between CH3 of the
terminal acetamide (H15) and H14 at the vicinal stereocentre
was also detected, indicating the presence of a small per-
centage of a cis-amide rotamer].[22,23] The CH3 acetyl hy-
drogen atoms (H15) also gave distinct cross-peaks with the
isopropyl CH3 hydrogen atoms of two different valine res-
idues (H11 and H13). The NH proton of the amidopyridine
(H1) gave cross-peaks with the proton of the valine ste-
reogenic centre (H9) and with the isopropyl CH proton
(H10). The aromatic protons of the phenylalanine ring gave
cross-peaks with the proton of the valine stereogenic centre
(H9), with CH2SO2 (H8), with the isopropyl CH3 (H11), and
with the isopropyl CH proton (H10). The benzylic protons
(H7) gave cross-peaks with the isopropyl CH3 (H11), and
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with the isopropyl CH proton (H10). The proton of the
phenylalanine stereogenic centre (H6) also gave cross-peaks
with the isopropyl CH3 (H11) and with the isopropyl CH
proton (H10). All these NOE contacts suggested an intram-
olecularly folded structure for the ‘‘two-armed’’ receptor 5,
produced by formation of a hydrogen-bonding network in-
volving the amidopyridine moiety and the different sulfona-
mide and acetyl groups of the two legs.
As further evidence of the strong self-association, com-
pound 5 initially proved to be a poorer receptor than com-
pound 1 for N-protected amino acids and N-protected di-
peptides (see Table 2). Compound 5 binds the amino acid
N-Cbz--Ala-OH approximately one order of magnitude
less tightly than compound 1 does (Ka 5 32 vs. 207 21).
The NH1 chemical shift was shifted downfield, but satura-
tion could not be reached even after addition of 20 equiv.
of guest.
Receptor 5 associates less strongly than receptor 1 with
N-Cbz--Ala--Ala-OH and with N-Boc--Ala--Phe-OH
(Ka 5 107 and 109 vs. 245 and 297 21, see Table 2). The
NH1 chemical shift was shifted downfield (ca. 0.3) but sat-
uration could not be reached even after addition of 15220
equiv. of dipeptide. The 1:1 stoichiometry of the complexes
between host 5 and the amino acidic and peptidic guests
was established by Scatchard plots[25] and by the good fit
of the experimental data to the 1:1 model.[26]
Titration of 5 with N-Cbz--Ala--Ala-OH gave a bind-
ing constant of 107 21 and a downfield shift of ä 5 0.3
for the amidopyridine NH1, but only small changes to the
sulfonamide and acetamide NH protons (NH2, NH3, NH4;
˜ä # 0.07). In contrast, titration of 5 with N-Cbz--Ala--
Ala-OH gave a binding constant of 2404 21, with a par-
ticularly large downfield shift for the sulfonamide NH3 sig-
nal (˜ä 5 0.72) but an upfield shift for the sulfonamide
NH2 (˜ä 5 0.38) and even a small upfield shift for the ami-
dopyridine NH1 (˜ä 5 0.05)! Binding of N-Cbz--Ala--
Ala-OH was also accompanied by significant shifts of sev-
eral CH signals in the host (up to ä 5 0.4 vs. # 0.08 in
the case of N-Cbz--Ala--Ala-OH). We also monitored the
chemical shifts of the N-protected amino acid and dipeptide
guests. The carbamate NHa signal of the amino acid sub-
strate was shifted downfield very modestly (ca. 0.03) on
binding with 5.[27] The carbamate NHa and amide NHb sig-
nals of the dipeptide substrates were more significantly
shifted downfield, most notably in the case of N-Cbz--Ala-
-Ala-OH in which the NHa signal shifted by ä 5 0.50 and
the NHb signal shifted by ä 5 0.42 on binding with 5 (in
the case of N-Cbz--Ala--Ala-OH, the NHa signal shifted
by ä 5 0.11 and the NHb signal shifted by ä 5 0.10 on
binding with 5).[27] Thus, receptor 5 displays remarkably
good enantioselectivity for the biologically significant Ala-
Ala-OH dipeptide sequence, albeit in a noncompetitive
solvent.
Conclusions
In conclusion, we have described the synthesis, the con-
formational behaviour and the binding properties of a novel
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class of synthetic ‘‘two-armed’’ receptors containing a 2,6-
diamidopyridine binding unit bearing pendant pseudopep-
tide legs consisting of an amino acid (-Phe) and various
chiral â-aminosulfonamides. These receptors collapse into
intramolecularly folded structures in CDCl3 solution,
through formation of a network of intramolecular hydrogen
bonds. Addition of excesses of N-protected amino acids and
dipeptides to receptors 1 or 5 involves unfolding of the re-
ceptor and breaking of intramolecular hydrogen bonds
(with an associated energy cost) to allow interaction with
the guest, resulting in rather low binding constants and only
small changes of the signals for the hydrogen-bonding NH
protons. Only a very qualitative picture of the conforma-
tional properties of the hosts and of the structure of their
complexes with protected amino acids and dipeptides could
be established; this is unfortunately also true for the inter-
esting enantioselectivity shown by host 5 in the recognition
of N-Cbz--Ala--Ala-OH.[28] In any event, the significant
shifts of several CH and NH signals throughout the spec-
trum of 5 (in particular the very large downfield shift for
the sulfonamide NH3) suggest that the structure of the com-
plex of N-Cbz--Ala--Ala-OH is very different from that
of the enantiomeric guest N-Cbz--Ala--Ala-OH. Such
high enantioselectivity (. 20:1, effectively discriminating
between methyl groups and hydrogen atoms) has seldom
been observed in synthetic receptors,[123][10b] and is particu-
larly noteworthy in such a structurally simple acyclic recep-
tor, which appears to lack much, if any, preorganisation for
binding. Work to develop a combinatorial approach to the
binding of dipeptides is in progress, either by the screening
of a library of receptors towards single substrates of inter-
est,[29] or by the screening of a library of dipeptides towards
a particular receptor.[30]
Experimental Section
General: Manipulations involving air-sensitive compounds were
carried out under argon. Anhydrous solvents were obtained from
sodium benzophenone ketyl (THF), or by refluxing over CaH2 for
at least 4 h prior to use. Reagents were used as received, without
any further purification, and were generally purchased from Ald-
rich and Fluka AG. Reactions in solution were monitored by ana-
lytical thin layer chromatography (TLC) by using Merck 60 F254
silica gel glass plates. The chromatograms were viewed under UV
light and by staining with a cerium reagent followed by heating.
Flash chromatography was performed with 60 silica gel (2302400
Mesh) purchased from Macherey2Nagel. NMR spectra were re-
corded with Bruker instruments (AC 200, AC 300 and AVANCE
400). The spectra are reported in ppm relative to tetramethylsilane.
General Procedure for Fmoc Removal from Resin-Bound Fmoc De-
rivatives: N-Fmoc-protected resins were treated with a 20% piperid-
ine/DMF solution (7 mL, 3 3 15 min). Between each cycle the so-
lution was drained and the resin was washed with DMF (13). At
the end of the third cycle, the resin was drained, washed with DMF
(33), MeOH (33) and DCM (43), and dried in vacuo.
2,6-Bis(N-Fmoc-L-Phe-NH)pyridine-4-OCH2CO-Gly-O-Wang-
Merrifield Resin (9): A solid-phase reactor was charged with N-
Fmoc-Gly-Wang-Merrifield resin 6 (0.260 mmol, 294 mg). Fmoc
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removal was accomplished according to the general procedure.
Acid 7 (0.217 mmol, 200 mg), HOBt (0.868 mmol, 117 mg), DIC
(0.868 mmol, 0.134 mL) and DMAP (0.108 mmol, 13 mg) were
then added. DCM (8 mL) was added and the resulting mixture was
shaken at room temperature for 20 h. The resin was drained,
washed with DMF (3 3 8 mL), MeOH (3 3 8 mL) and DCM (4
3 8 mL), and dried in vacuo. Yield: 426 mg, 98%. Acetylimidazole
(2.170 mmol, 239 mg) and DCM (8 mL) were then added and the
mixture was shaken at room temperature for 2 h. The solution was
then filtered and the resin was washed with DMF (3 3 8 mL),
MeOH (3 3 8 mL) and DCM (4 3 8 mL), and dried in vacuo.
2,6-Bis[(S)-N-FmocNHCH(iPr)CH2SO2-L-Phe-NH]pyridine-4-
OCH2CO-Gly-O-Wang-Merrifield Resin (10): A solid-phase re-
actor was charged with 2,6-bis(Fmoc--Phe-NH)pyridine-4-
OCH2CO-gly-O-Wang-Merrifield resin 9 (0.163 mmol, 320 mg),
and Fmoc removal was performed according to the general proced-
ure. Sulfonyl chloride 8 (0.652 mmol, 267 mg), DMAP
(0.130 mmol, 16 mg) and DCM (8 mL) were then added and the
mixture was shaken for 5 min; MTDA (1.300 mmol, 0.264 mL) was
added and the mixture was shaken at room temperature overnight.
The suspension was then filtered and the resin was washed with
DMF (3 3 8 mL), MeOH (3 3 8 mL) and DCM (4 3 8 mL), and
dried in vacuo. Yield: 334 mg, 92%. The free amino content was
checked by two different tests: The TNBS test was negative,[31]
while the NF31 test,[32] a more sensitive assay, revealed the presence
of approximately 2% free amino content (slightly pink-red beads).
A basic washing was performed by addition of a solution of 5%
DIPEA in DMF (4 mL). This washing was done twice and the
resin was washed with DMF (3 3 8 mL), MeOH (3 3 8 mL) and
DCM (4 3 8 mL), and dried in vacuo. A second coupling cycle was
then performed under the same conditions: 8 (0.163 mmol, 66 mg),
DMAP (0.032 mmol, 4 mg), MTDA (0.326 mmol, 66 ìL), and
DCM (4 mL). Yield: 338 mg, 93%. After washing, both tests were
clearly negative (colourless beads).
2,6-Bis[(S)-N-FmocNHCH(iPr)CH2SO2-(S)-NHCH(iPr)CH2SO2-
L-Phe-NH]pyridine-4-OCH2CO-Gly-O-Wang-Merrifield Resin
(14): A solid-phase reactor was charged with 2,6-bis[(S)-N-Fmoc-
NHCH(iPr)CH2SO2--Phe-NH]pyridine-4-OCH2CO-gly-O-Wang-
Merrifield resin 10 (0.095 mmol, 169 mg), and Fmoc removal was
performed according to the general procedure. Sulfonyl chloride 8
(0.380 mmol, 155 mg), DMAP (0.076 mmol, 9 mg) and DCM
(6 mL) were then added and the mixture was shaken for 5 min;
MTDA (0.760 mmol, 0.154 mL) was added and the mixture was
shaken at room temperature overnight. The suspension was then
filtered and the resin was washed with DMF (3 3 8 mL), MeOH
(3 3 8 mL) and DCM (4 3 8 mL), and dried in vacuo. Yield:
163 mg, 84%. The free amino content was checked by two different
tests: The TNBS test was negative,[31] while the NF31 test[32] re-
vealed the presence of free amino content (slightly pink-red beads).
A basic washing was performed by addition of a solution of 5%
DIPEA in DMF (4 mL). This washing was performed twice and
the resin was washed with DMF (3 3 8 mL), MeOH (3 3 8 mL)
and DCM (4 3 8 mL), and dried in vacuo. A second coupling cycle
was then performed under the same conditions: 8 (0.190 mmol,
78 mg), DMAP (0.032 mmol, 4 mg), MTDA (0.380 mmol, 77 ìL)
and DCM (4 mL). Yield: 179 mg, 92%. After washing, both tests
were clearly negative (colourless beads).
General Procedure for the Acetylation of Resin-Bound Fmoc Deriv-
atives: A solid-phase reactor was charged with Fmoc-protected
resins (9 or 10) and Fmoc removal was performed according to the
general procedure. Acetylimidazole (10 equiv.) and DCM (2 mL
per 0.054 mmol) were then added and the mixture was shaken over-
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night at room temperature. The solution was then filtered and the
resin was washed with DMF (33), MeOH (33) and DCM (43)
and dried in vacuo.
Mesylation of 2,6-Bis[(S)-N-FmocNHCH(iPr)CH2SO2-L-Phe-
NH]pyridine-4-OCH2CO-Gly-O-Wang-Merrifield Resin (10): A
solid-phase reactor was charged with resin 10 (0.054 mmol), and
Fmoc removal was performed according to the general procedure.
Mesyl chloride (10 equiv.), TEA (12 equiv.) and DCM (4 mL) were
added and the mixture was shaken at room temperature overnight.
The resin was drained, washed with a 10% solution of TEA in
DCM (33), DMF (33), MeOH (33) and DCM (43), and dried
in vacuo.
Cleavage of the 2,6-Diamidopyridine Derivatives from the Resin
General Procedure A (Basic Cleavage):[33] The appropriate resin was
treated with an anhydrous TEA/MeOH/DMF solution (4.7 mL,
1.9:1.9:0.9, v/v/v) under argon. The mixture was magnetically
stirred at 50° C for 24 h. The suspension was then filtered and the
resin was washed with DCM (33). The eluates were pooled and
the solvents were evaporated under reduced pressure to afford a
residue that was subsequently purified.
General Procedure B (Acidic Cleavage): The appropriate resin was
treated with TFA/H2O solution (95:5 v/v) (5 mL). The mixture was
shaken for 4 min. The solution was then drained and the resin was
washed with DCM (33). A second cycle was performed. The elu-
ates were pooled and the solvents were evaporated under reduced
pressure to afford a residue that was treated with dry toluene and
sonicated for 1 or 2 min. The solvent was evaporated (the treatment
was repeated three more times). The resulting white solid was dried
in vacuo, to yield the acid derivative in 85290% overall yield. The
acid was mixed with EDC (4 equiv.), DMAP (0.5 equiv.) and dry
THF (4.5 mL/0.043 mmol of acid), and the mixture was stirred for
5 min. Dry MeOH (629 equiv.) was then added and the reaction
mixture was stirred at room temperature overnight. Evaporation of
the solvent under reduced pressure afforded a residue, which was
subsequently purified.
2,6-Bis[(S)-N-AcNHCH(iPr)CH2SO2-L-Phe-NH]pyridine-4-OCH2-
CO-Gly-OMe (1): By general procedure A. The crude residue was
purified by flash column chromatography on silica gel, with DCM/
acetone (5%) and DCM/MeOH (125%) as eluents. The yellow
solid obtained was precipitated from DCM/diethyl ether to give a
white solid in 30% overall yield. By general procedure B. The crude
residue was purified by flash column chromatography on silica gel,
with DCM/acetone (5%) and DCM/MeOH (226%) as eluents. The
white solid obtained was precipitated from DCM/diethyl ether to
give a white solid in 35% overall yield. 1: 1H NMR (200 MHz,
5 m in [D6]DMSO, 307 K): ä 5 10.27 (s, 2 H, Py-NHCO), 8.74
(t, J 5 5.0 Hz, 1 H, NH-Gly), 7.85 (br. s, 2 H, NHSO2), 7.70 (d,
J 5 10.0 Hz, 2 H, NHAc), 7.62 (s, 2 H, CH-Py), 7.5027.32 (m, 10
H, aromatic), 4.73 (s, 2 H, O-CH2-Gly), 4.5024.48 (m, 2 H, CH-
Phe), 4.1224.08 (m, 2 H, CH-iPr), 4.02 (d, J 5 5.0 Hz, 2 H, CH2-
Gly), 3.74 (s, 3 H, OMe), 3.3022.65 (m, 4 H, CH2Ph), 2.6022.30
(m, 4 H, CH2SO2), 1.88 (s, 6 H, CH3CO), 1.7021.68 (m, 2 H,
CHMe2), 0.77 (d, 12 H, J 5 7.0 Hz, CH3). 1H NMR (400 MHz,
3.8 m in CDCl3, 300 K): ä 5 9.30 (br. s, 2 H, Py-NHCO), 7.58
(br. s, 1 H, NH-Gly), 7.3727.28 (m, 12 H, aromatic), 6.27 (br. s, 2
H, NHSO2), 6.05 (br. s, 2 H, NHAc), 4.50 (br. s, 4 H, O2CH2-Gly
and CH-Phe), 4.1724.12 (m, 4 H, CH-iPr and CH2-Gly), 3.77 (s,
3 H, OMe), 3.3723.35 (m, 2 H, CH2Ph), 3.0322.92 (m, 4 H,
CH2SO2), 2.8222.79 (m, 2 H, CH2Ph), 1.97 (s, 6 H, CH3CO),
1.7621.74 (m, 2 H, CHMe2), 0.80 (d, J 5 7.0 Hz, 6 H, CH3), 0.79
(d, J 5 7.0 Hz, 6 H, CH3). 13C NMR (50.3 MHz, 5 m, [D6] acet-
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one, 300 K): ä 5171.4, 170.5, 167.8, 167.4 (CO), 151.8, 138.0 (C,
arom.), 130.5, 129.1, 127.6 (CH, arom.), 96.5 (CH, Py), 67.3 (CH2,
OCH2CO), 59.9 (CH, CH-Phe), 55.3 (CH2, CH2SO2), 52.0 (CH3,
OCH3), 50.4 (CH, CH-iPr), 40.9 (CH2, CH2-Gly), 39.0 (CH2,
CH2Ph), 32.5 (CH, CHMe2), 22.9 (CH3, CH3CO), 19.1 (CH3), 17.5
(CH3). MS (FAB): m/z 5 931 [M 1 H]1; 953 [M 1 Na]1. HRMS
(FAB) calcd. for C42H59N8O12S2 [M 1 H]1: 931.36884, found m/
z: 931.36869.
2,6-Bis[(S)-N-MsNHCH(iPr)CH2SO2-L-Phe-NH]pyridine-4-
OCH2CO-Gly-OMe (2): This compound was prepared by general
procedure A. The crude residue was purified by flash column chro-
matography on silica gel, with DCM/acetone (5%) and DCM/
MeOH (3%) as eluents. The yellow solid obtained was precipitated
from DCM/diethyl ether to give a white solid in 30% overall yield.
2: 1H NMR (200 MHz, 5 m in [D6]DMSO, 300 K): ä 5 10.77 (s,
2 H, Py-NHCO), 8.7828.76 (m, 1 H, NH-Gly), 8.1328.11 (m, 2
H, NHSO2), 7.61 (s, 2 H, CH-Py), 7.5027.32 (m, 12 H, aromatic,
NHSO2), 4.73 (s, 2 H, O2CH2-Gly), 4.4024.60 (m, 2 H, CH-Phe),
4.02 (d, J 5 5.0 Hz, 2 H, CH2-Gly), 3.73 (s, 3 H, OMe), 3.6323.59
(m, 2 H, CH-iPr), 3.3022.65 (m, 4 H, CH2Ph), 2.98 (s, 6 H,
CH3SO2), 2.6022.30 (m, 4 H, CH2SO2), 1.8821.74 (m, 2 H,
CHMe2), 0.76 (d, J 5 7.0 Hz, 6 H, CH3), 0.75 (d, J 5 7.0 Hz, 6
H, CH3). 1H NMR (400 MHz, 5 m in CDCl3, 300 K): ä 5 9.07
(br. s, 2 H, Py-NHCO), 7.65 (br. s, 1 H, NH-Gly), 7.3827.28 (m,
12 H, aromatic), 6.34 (br. s, 2 H, NHSO2), 5.13 (br. s, 2 H,
NHSO2), 4.54 (s, 2 H, O2CH2-Gly), 4.41 (br. s, 2 H, CH-Phe),
4.20 (br. s, 2 H, CH2-Gly), 3.79 (s, 3 H, OMe), 3.7023.60 (m, 2 H,
CH-iPr), 3.4723.16 (m, 2 H, CH2Ph), 3.1422.91 (m, 8 H, CH2Ph
and CH3SO2), 2.8022.55 (m, 2 H, CH2SO2), 2.5022.33 (m, 2 H,
CH2SO2), 2.0221.90 (m, 2 H, CHMe2), 0.86 (br. s, 12 H, CH3).
13C NMR (50.3 MHz, 10 m, CDCl3, 300 K): ä 5 170.2, 167.6,
166.1 (CO), 150.2, 136.4 (C, arom.), 129.7, 128.0, 127.4 (CH,
arom.), 96.3 (CH, Py), 66.7 (CH2, OCH2CO), 59.8 (CH, CH-Phe),
55.0 (CH3, OCH3), 53.5 (CH2, CH2SO2), 52.3 (CH, CH-iPr), 41.8
(CH3, CH3SO2), 40.7 (CH2, CH2-Gly), 38.6 (CH2, CH2Ph), 32.5
(CH, CHMe2), 17.9 (CH3), 17.6 (CH3). MS (FAB): m/z 5 1003 [M
1 H]1; 1025 [M 1 Na]1. HRMS (FAB) calcd. for C40H59N8O14S4
[M 1 H]1: 1003.30281, found m/z: 1003.30330.
2,6-Bis(N-Ac-L-Phe-NH)pyridine-4-OCH2CO-Gly-OMe (3): This
compound was prepared by general procedure A. The yellow solid
obtained was precipitated twice from DCM/diethyl ether to give a
white solid in 30% overall yield. 3: 1H NMR (200 MHz, 8.5 in
[D6]acetone, 300 K): ä 5 9.39 (s, 2 H, Py-NHCO), 8.07 (t, J 5
6.0 Hz, 1 H, NH-Gly), 7.76 (d, J 5 8.0 Hz, 2 H, NHAc), 7.42 (s,
2 H, CH-Py), 7.3527.10 (m, 10 H, aromatic), 4.9624.85 (m, 2 H,
CH-Phe), 4.53 (s, 2 H, O2CH2-Gly), 4.01 (d, J 5 6.0 Hz, 2 H,
CH2-Gly), 3.63 (s, 3 H, OMe), 3.2923.19 (m, 2 H, CH2Ph),
3.0222.90 (m, 2 H, CH2Ph), 1.90 (s, 6 H, CH3CO). 1H NMR
(400 MHz, 8.5 in CDCl3, 300 K): ä 5 8.83 (s, 2 H, Py-NHCO),
7.35 (br. s, 1 H, NH-Gly), 7.3327.23 (m, 12 H, aromatic), 6.56 (d,
J 5 8.0 Hz, 2 H, NHAc), 4.9624.91 (m, 2 H, CH-Phe), 4.49 (s, 2
H, O2CH2-Gly), 4.1724.11 (m, 2 H, CH2-Gly), 3.78 (s, 3 H,
OMe), 3.3323.27 (m, 2 H, CH2Ph), 3.1423.09 (m, 2 H, CH2Ph),
2.03 (s, 6 H, CH3CO). 13C NMR (75.4 MHz, 8.5 m, CDCl3,
300 K): ä 5 171.4, 170.2, 167.6, 166.1 (CO), 150.6, 136.4 (C,
arom.), 129.2, 128.6, 127.0 (CH, arom.), 96.3 (CH, Py), 66.8 (CH2,
OCH2CO), 55.3 (CH, CH-Phe), 52.3 (CH3, OCH3), 40.7 (CH2,
CH2-Gly), 37.1 (CH2, CH2Ph), 23.2 (CH3, CH3CO). MS (FAB):
m/z 5 633 [M 1 H]1; 655 [M 1 Na]1. HRMS (FAB) calcd. for
C32H37N6O8 [M 1 H]1: 633.26674, found m/z: 633.26722.
2-[(S)-N-AcNHCH(iPr)CH2SO2-L-Phe-NH]-6-(N-Alloc-L-Phe-
NH)pyridine-4-OCH2CO-Gly-OBn (4): The asymmetric scaffold 11
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(33 mg, 0.044 mmol) was dissolved in a solution of 25% (v/v) TFA
in dry DCM (1.5 mL). The solution was stirred at room temper-
ature for 1.5 h, diluted with DCM (100 mL), and washed with a
10% aqueous solution of K2CO3 and brine. The organic layer was
dried with Na2SO4 and filtered, and the solvents were evaporated.
The sulfonyl chloride 12 (25 mg, 0.088 mmol), DMAP (8 mg,
0.066 mmol), dry DCM (2 mL) and MTDA (36 ìL) were then ad-
ded to the free amine (28 mg, 0.044 mmol). The mixture was stirred
at room temperature for 2 h 30. DCM was removed and the residue
was dissolved in EtOAc (75 mL). The organic layer was washed
with a 10% aqueous solution of citric acid (3 3 10 mL) and brine
(10 mL), dried with Na2SO4 and filtered. The solvents were evapor-
ated to give the N-Boc-protected compound 13 (39 mg, 99% yield).
Compound 13 (39 mg, 0.043 mmol) was dissolved in a solution of
25% (v/v) TFA in DCM (1.0 mL). The solution was stirred at room
temperature for 1 h and the DCM was evaporated. Dry toluene (2
mL) was added to the residue. The mixture was sonicated and the
toluene was evaporated (3 cycles). The residue was dissolved in
DCM (2 mL) and Aclm was added (34 mg, 0.305 mmol). The mix-
ture was stirred at room temperature overnight. DCM was evapor-
ated and the residue was dissolved in EtOAc (75 mL). The organic
layer was washed with a 10% aqueous solution of citric acid (3 3
10 mL), and then with a 10% aqueous solution of NaHCO3 (3 3
10 mL) and brine (10 mL), dried with Na2SO4 and filtered. The
solvents were evaporated to give 33 mg (90%) of compound 4,
which could not be further purified. 4: 1H NMR (400 MHz, 8.5 m
in CDCl3, 300 K): ä 5 8.87 (s, 1 H, Py-NHCO), 8.75 (s, 1 H, Py-
NHCO), 7.4127.23 (m, 17 H, aromatic), 5.98 (br. s, 1 H, NH-SO2),
5.8725.79 (m, 2 H, CH5C and NH-Ac), 5.74 (br. s, 1 H, NH-
Alloc), 5.28 (s, 2 H, O2CH2-Ph), 5.2325.14 (m, 2 H, CH25C),
4.67 (s, 2 H, O2CH2-CO), 4.5724.55 (m, 1 H, CH-Phe), 4.5324.51
(m, 2 H, CH2-Alloc), 4.47 (br. s, 1 H, CH-Phe), 4.2424.20 (m, 1
H, CH-iPr), 3.3423.24 (m, 2 H, CH2Ph), 3.0822.82 (m, 4 H,
CH2Ph and CH2SO2), 1.95 (s, 3 H, CH3CO), 1.7221.70 (m, 1 H,
CHMe2), 0.82 (d, J 5 7.0 Hz, 6 H, CH3). MS (FAB): m/z 5 843
[M 1 H]1; 865 [M 1 Na]1. HRMS (FAB) calcd. for
C43H51N6O10S [M 1 H]1: 843.33819, found m/z: 843.33657.
2,6-Bis[(S)-N-AcNHCH(iPr)CH2SO2-(S)-NHCH(iPr)CH2SO2-L-
Phe-NH]pyridine-4-OCH2CO-Gly-OMe (5): By general procedure
B. The crude residue was purified by flash column chromatography
on silica gel, with DCM/EtOH (5%)/EtOAc (5%) as eluents. The
white solid obtained was precipitated from DCM/diethyl ether to
give a white solid in 20% overall yield. 5: 1H NMR (200 MHz,
20 m in CD3CN, 300 K): ä 5 9.18 (s, 2 H, Py-NH1CO),
7.5827.48 (3 H, NH-Gly and CH-Py), 7.3327.21 (m, 10 H, aro-
matic), 6.56 (d, J 5 6.0 Hz, 2 H, NH3-SO2), 6.38 (d, J 5 10.0 Hz,
2 H, NH4-CO), 5.71 (d, J 5 10.0 Hz, 2 H, NH2-SO2), 4.58 (s, 2 H,
O2CH2-Gly), 4.3824.29 (m, 4 H, CH9-iPr and CH14-iPr), 3.96 (d,
J 5 6.0 Hz, 2 H, CH2-Gly), 3.7123.65 (m, 5 H, OMe and CH6-
Phe), 3.2622.63 (m, 12 H, CH122 SO2 and CH82SO2 and CH72Ph),
1.88 (s, 6 H, CH153 CO), 1.8221.73 (m, 4 H, CH10Me2 and
CH16Me2), 0.8720.70 (m, 24 H, CH133 and CH113 ). 1H NMR
(400 MHz, 2 m in CDCl3, 300 K): ä 5 9.27 (s, 2 H, Py-NH1CO),
7.43 (br. s, 1 H, NH-Gly), 7.3727.28 (m, 12 H, aromatic), 6.24 (br.
s, 2 H, NH3-SO2), 6.17 (br. s, 2 H, NH4-CO), 5.72 (br. s, 2 H, NH2-
SO2), 4.57 (s, 2 H, O2CH2-Gly), 4.46 (br. s, 4 H, CH9-iPr and
CH14-iPr), 4.17 (s, 2 H, CH2-Gly), 3.79 (br. s, 5 H, OMe and CH6-
Phe), 3.4023.37 (m, 4 H, CH122 SO2 and CH82SO2), 3.2023.12 (m,
2 H, CH122 SO2), 3.0322.97 (m, 2 H, CH82SO2), 2.77 (br. s, 2 H, CH
7
2Ph), 2.56 (br. s, 2 H, CH72Ph), 2.04 (br. s, 8 H, CH153 CO and
CH16Me2), 1.88 (br. s, 2 H, CH10Me2), 0.89 (br. s, 12 H, CH133 ),
0.77 (br. s, 12 H, CH113 ). 13C NMR (100.6 MHz, 20 m in CDCl3,
300 K): ä 5 172.3, 170.9, 168.1, 166.7 (CO), 151.0, 137.1 (C,
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arom.), 130.2, 129.2, 127.8 (CH, arom.), 97.1 (CH, Py), 67.2 (CH2,
OCH2CO), 60.2 (CH, CH-Phe), 56.1 (CH2, CH2SO2), 55.1 (CH3,
OCH3), 52.8 (CH, CH-iPr), 50.8 (CH, CH-iPr), 41.2 (CH2, CH2,
CH2-Ph), 39.2 (CH2-Gly), 33.7 (CH, CHMe2), 32.1 (CH, CHMe2),
23.8 (CH3, CH3CO), 19.6 (CH3), 18.2 (CH3). MS (FAB): m/z 5
1230 [M 1 H]1; 1252 [M 1 Na]1. HRMS (FAB) calcd. for
C52H81N10O16S4 [M 1 H]1: 1229.47094, found m/z: 1229.47036.
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